Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;30(4):2325-2336.
doi: 10.1111/odi.14725. Epub 2023 Sep 24.

DNA methyltransferase 3A induces the occurrence of oral submucous fibrosis by promoting the methylation of the von Hippel-Lindau

Affiliations

DNA methyltransferase 3A induces the occurrence of oral submucous fibrosis by promoting the methylation of the von Hippel-Lindau

Huifang Kuang et al. Oral Dis. 2024 May.

Abstract

Background: Oral submucous fibrosis (OSF) is associated with malignant disorders. DNA methyltransferase 3A (DNMT3A) is a DNA methylesterase reported to be upregulated in multiple organs and shown to inhibit fibrosis. However, the detailed effect of DNMT3A on OSF remains unclear.

Methods: To mimic OSF in vitro, oral fibroblasts were exposed to arecoline and molecular biological experiments were performed to detect the function of DNMT3A in OSF.

Results: We found that von Hippel-Lindau (VHL) was downregulated and highly methylated in OSF. Arecoline remarkably increased the viability, invasiveness, and migration of oral fibroblasts, but upregulation of VHL partially reversed these effects. DNMT3A induces DNA hypermethylation in the VHL promoter, and VHL markedly inhibits the level of tenascin-C (TNC) by inducing the ubiquitination of TNC. TNC reversed the inhibitory effect of VHL upregulation on the differentiation of oral fibroblasts into myofibroblasts.

Conclusion: DNMT3A induces OSF by promoting methylation of the VHL promoter. Hence, our study provides novel insights into the discovery of novel strategies that can be employed against OSF.

Keywords: DNA methyltransferase 3A; methylation; tenascin‐C; von Hippel–Lindau.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Brunetti, L., Gundry, M. C., & Goodell, M. A. (2017). DNMT3A in leukemia. Cold Spring Harbor Perspectives in Medicine, 7(2), a030320.
    1. Carey, W. A., Taylor, G. D., Dean, W. B., & Bristow, J. D. (2010). Tenascin‐C deficiency attenuates TGF‐ss‐mediated fibrosis following murine lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology, 299(6), L785–L793.
    1. Chittiboina, P., & Lonser, R. R. (2015). von Hippel–Lindau disease. Handbook of Clinical Neurology, 132, 139–156.
    1. Dees, C., Potter, S., Zhang, Y., Bergmann, C., Zhou, X., Luber, M., Wohlfahrt, T., Karouzakis, E., Ramming, A., Gelse, K., Yoshimura, A., Jaenisch, R., Distler, O., Schett, G., & Distler, J. H. W. (2020). TGF‐beta‐induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis. The Journal of Clinical Investigation, 130(5), 2347–2363.
    1. Ganner, A., Gehrke, C., Klein, M., Thegtmeier, L., Matulenski, T., Wingendorf, L., Wang, L., Pilz, F., Greidl, L., Meid, L., Kotsis, F., Walz, G., Frew, I. J., & Neumann‐Haefelin, E. (2021). VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma. Scientific Reports, 11(1), 14827.

Publication types

MeSH terms

Substances

LinkOut - more resources